All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Expert consensus statement for periprocedural anticoagulation and antiplatelet therapy in elective bronchoskopy

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F16%3A33159326" target="_blank" >RIV/61989592:15110/16:33159326 - isvavai.cz</a>

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Expert consensus statement for periprocedural anticoagulation and antiplatelet therapy in elective bronchoskopy

  • Original language description

    This procedure is designed to minimize the risk of bleeding and thromboembolic complications in periprocedurálním period endoscopic procedure. For this reason, it is appropriate to divide patients into groups with low, medium and high risk of thromboembolism (TE) and endoscopic procedures into groups with low and high risk of bleeding. Generally speaking, with increase of risk which has to be the lowest limit or shortest discontinuation of anticoagulant therapy. On the other hand, with a growing risk of bleeding because power is necessary to extend the period during which anticoagulant therapy is discontinued. An important parameter is also the time of thromboembolic episodes until the planned performance. Patients with a history of venous thromboembolism elective surgery should not be performed in the first three months after the attack of TEN. In patients with thromboembolic complications of atrial fibrillation (AF) is the most risky first month of the documentation TE complications and elective surgery should be postponed to as late as possible dates. The procedure shows recommendations regarding the withdrawal and re-deployment of anticoagulant and antithrombotic therapy in patients progressing bronchoscopic examination. Below are possible laboratory methods for monitoring the effectiveness of anticoagulant and antiplatelet therapy on coagulation system and possible methods of therapy eventual periprocedurálního bleeding due to anticoagulation or antiplatelet therapy.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FC - Pneumology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2016

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Cor et Vasa

  • ISSN

    0010-8650

  • e-ISSN

  • Volume of the periodical

    58

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    6

  • Pages from-to

    175-180

  • UT code for WoS article

  • EID of the result in the Scopus database